Target type: biologicalprocess
The covalent alteration of one or more fatty acids in a lipid, resulting in a change in the properties of the lipid. [GOC:mah]
Lipid modification is a crucial biological process that involves the alteration of lipids, which are essential components of cell membranes and play vital roles in various cellular functions. These modifications can alter the physical properties, biological activity, and signaling capabilities of lipids.
Here's a detailed breakdown of the process:
**1. Types of Lipid Modifications:**
* **Acylation:** The addition of a fatty acid chain to a lipid molecule. This process commonly occurs on proteins, adding hydrophobic regions that can anchor them to membranes.
* **Glycosylation:** The attachment of sugar molecules (glycans) to lipids, forming glycolipids. This modification can alter the charge, polarity, and recognition properties of lipids, playing a role in cell signaling and recognition.
* **Phosphorylation:** The addition of a phosphate group to a lipid molecule. This modification can regulate the activity of enzymes and proteins involved in lipid metabolism and signal transduction.
* **Prenylation:** The attachment of isoprenoid groups to lipids. This process is crucial for the localization and activity of proteins involved in cell signaling, membrane trafficking, and cytoskeletal organization.
* **Sulfation:** The addition of a sulfate group to a lipid molecule. This modification can alter the charge and interactions of lipids, influencing their biological activity and signaling properties.
* **Methylation:** The addition of a methyl group to a lipid molecule. This modification can regulate the activity of enzymes and proteins involved in lipid metabolism and signal transduction.
**2. Enzymes Involved:**
Lipid modifications are catalyzed by specific enzymes that recognize and act on particular lipid substrates. These enzymes include acyltransferases, glycosyltransferases, kinases, prenyltransferases, sulfotransferases, and methyltransferases.
**3. Biological Significance:**
* **Membrane Structure and Function:** Lipid modifications influence the fluidity, stability, and curvature of cell membranes, affecting their overall structure and function.
* **Cell Signaling:** Modified lipids can act as signaling molecules, transmitting information within and between cells. For example, phosphoinositides play crucial roles in signaling pathways involved in cell growth, differentiation, and survival.
* **Protein Function:** Lipid modifications can alter the localization, activity, and interactions of proteins, affecting their overall function.
* **Disease Relevance:** Aberrant lipid modifications have been implicated in various diseases, including cancer, neurodegenerative disorders, and metabolic diseases.
**4. Regulation:**
Lipid modifications are tightly regulated processes, ensuring proper cellular function. The activity of modifying enzymes is controlled by factors such as substrate availability, cellular environment, and signaling pathways.
**5. Examples:**
* **Sphingomyelin synthesis:** Involves the acylation of ceramide to form sphingomyelin, a major component of cell membranes.
* **Glycosphingolipid synthesis:** The glycosylation of ceramides generates various glycosphingolipids, which are involved in cell recognition and adhesion.
* **Phosphatidylinositol signaling:** Phosphorylation of phosphatidylinositol generates various phosphoinositides, which act as signaling molecules in diverse cellular processes.
Overall, lipid modifications represent a complex and essential regulatory mechanism that plays a critical role in various cellular functions. Understanding the intricacies of lipid modifications is crucial for comprehending cellular processes and developing therapies for associated diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ghrelin O-acyltransferase | A ghrelin O-acyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96T53] | Homo sapiens (human) |
Protein-serine O-palmitoleoyltransferase porcupine | A protein-serine O-palmitoleoyltransferase porcupine that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H237] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
ethylmaleimide | Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies. | maleimides | anticoronaviral agent; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.1.1 (hexokinase) inhibitor |
estrone | Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens. | 17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols | antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite |
2-cyclohexen-1-one | 2-cyclohexen-1-one: RN given refers to unlabeled cpd with specified locant for double bond cyclohex-2-enone : A cyclohexenone having its C=C double bond at the 2-position. cyclohexenone : The parent compound of the cyclohexenones, composed of cyclohexanone having one double bond in the ring. | cyclohexenone | |
ursolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | geroprotector; plant metabolite | |
cholest-4-en-3-one | cholest-4-en-3-one : A cholestanoid that is cholest-4-ene substituted by an oxo group at position 3. | 3-oxo-Delta(4) steroid; cholestanoid | human metabolite; plant metabolite |
taraxerol | taraxerol : A pentacyclic triterpenoid that is oleanan-3-ol lacking the methyl group at position 14, with an alpha-methyl substituent at position 13 and a double bond between positions 14 and 15. taraxerol: structure | pentacyclic triterpenoid; secondary alcohol | metabolite |
androstan-3-one | |||
Bardoxolone | cyclohexenones | ||
bardoxolone methyl | methyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate: structure in first source | cyclohexenones | |
N-(6-methyl-1,3-benzothiazol-2-yl)-2-[(4-oxo-3-phenyl-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl)thio]acetamide | organic heterobicyclic compound; organonitrogen heterocyclic compound; organosulfur heterocyclic compound | ||
1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole | |||
2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide | 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid ethyl amide: synthetic potential anticarcinogenic | ||
lgk974 | LGK974 : A carboxamide, the structure of which is that of acetamide substituted on carbon by a 2',3-dimethyl-2,4'-bipyridin-5-yl group and on nitrogen by a 5-(pyrazin-2-yl)pyridin-2-yl group. It is a highly potent, selective and orally bioavailable Porcupine inhibitor (a Wnt signalling inhibitor). LGK974: a potent and specific small-molecule inhibitor of Porcupine (PORCN) acyltransferase | bipyridines; pyrazines; pyridines; secondary carboxamide | Wnt signalling inhibitor |
wnt-c59 | 2-(4-(2-methylpyridin-4-yl)phenyl)-N-(4-(pyridin-3-yl)phenyl)acetamide: a PORCN acyltransferase inhibitor; structure in first source |